RhumbLine Advisers
NEXI

RhumbLine Advisers’s NexImmune, Inc. Common Stock NEXI Stock Holding History

RhumbLine Advisers’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-560
Closed -$59K – 3271
2022
Q1 		$59K Buy
560
+159
+40% +$11.7K ﹤0.01% 2962
2021
Q4 		$46K Sell
401
-12
-3% -$2.88K ﹤0.01% 2984
2021
Q3 		$156K Buy
+413
New +$139K ﹤0.01% 2946

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

RhumbLine Advisers's NEXI Position: Q2 2022 in Review

RhumbLine Advisers sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2022, closing a stake of 560 shares — an estimated $59K sold.

RhumbLine Advisers first reported a position in NEXI in Q3 2021 and held it in 3 quarters. The position peaked at $156K in Q3 2021. 44 funds tracked by Wall St. Rank hold NEXI as of Q2 2022.

  • RhumbLine Advisers reported no remaining NexImmune, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 560 NexImmune, Inc. Common Stock shares in Q2 2022, an estimated $59K.
  • RhumbLine Advisers first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • RhumbLine Advisers's NexImmune, Inc. Common Stock position peaked at $156K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.